SCHOLAR ROCK HOLDING CORPORATION Financials Scholar Rock Holding Corporation
Equities
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.53 USD | +4.08% |
|
+4.91% | -22.71% |
| Mar. 28 | Scholar Rock Shares Rise After Raymond James Initiates Coverage | MT |
| Mar. 28 | Raymond James Initiates Scholar Rock With Strong Buy Rating, $30 Price Target | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 391.2 | 1,632 | 872.1 | 467.6 | 1,356 | 1,159 | - | - |
| Enterprise Value (EV) 1 | 391.2 | 1,497 | 709.3 | 414 | 1,356 | 886.4 | 760.3 | 746.2 |
| P/E ratio | -7.12 x | -17.3 x | -6.92 x | -4 x | -9.45 x | -7.16 x | -7.76 x | -13.4 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 19.1 x | 106 x | 46.3 x | 14.1 x | - | - | 40.4 x | 8.2 x |
| EV / Revenue | 19.1 x | 97.2 x | 37.7 x | 12.5 x | - | - | 26.5 x | 5.28 x |
| EV / EBITDA | - | -17,529,769 x | -5,571,747 x | - | - | - | - | - |
| EV / FCF | -5.99 x | -23.3 x | -5.37 x | -3.1 x | - | -4.82 x | -4.44 x | -9.43 x |
| FCF Yield | -16.7% | -4.3% | -18.6% | -32.3% | - | -20.7% | -22.5% | -10.6% |
| Price to Book | - | 6.36 x | 5.3 x | 2.07 x | - | 5.62 x | 4.55 x | 4.76 x |
| Nbr of stocks (in thousands) | 29,678 | 33,639 | 35,108 | 51,663 | 72,143 | 79,745 | - | - |
| Reference price 2 | 13.18 | 48.53 | 24.84 | 9.050 | 18.80 | 14.53 | 14.53 | 14.53 |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 20.49 | 15.4 | 18.82 | 33.19 | - | - | 28.71 | 141.2 |
| EBITDA | - | -85.39 | -127.3 | - | - | - | - | - |
| EBIT 1 | -54.54 | -86.88 | -129.9 | -134.4 | -171.3 | -200 | -206.9 | -122.3 |
| Operating Margin | -266.16% | -564.03% | -690.48% | -404.81% | - | - | -720.72% | -86.58% |
| Earnings before Tax (EBT) 1 | -51 | -86.48 | -131.8 | -134.5 | -165.8 | -196.3 | -197.6 | -130.5 |
| Net income 1 | -51 | -86.48 | -131.8 | -134.5 | -165.8 | -195.6 | -199.2 | -116.9 |
| Net margin | -248.88% | -561.47% | -700.46% | -405.21% | - | - | -693.74% | -82.74% |
| EPS 2 | -1.850 | -2.810 | -3.590 | -2.260 | -1.990 | -2.029 | -1.872 | -1.087 |
| Free Cash Flow 1 | -65.34 | -64.36 | -132 | -133.8 | - | -183.9 | -171.2 | -79.15 |
| FCF margin | -318.87% | -417.83% | -701.73% | -402.97% | - | - | -596.2% | -56.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5.464 | 4.049 | 33.19 | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | -38.35 | - | - | - | - | - | - | - |
| EBIT 1 | -37.08 | -35.36 | -6.933 | -43.15 | -43.86 | -40.43 | -40.51 | -39.08 | -43.67 | -48.03 | -47.74 | -48.65 | -50 | -51.51 | -60.03 |
| Operating Margin | -678.57% | -873.4% | -20.89% | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -37.51 | -35.91 | -7.95 | -44 | -43.3 | -39.26 | -39.38 | -37.92 | -42.36 | -46.13 | -47.14 | -48.17 | -49.64 | -51.34 | -55.75 |
| Net income 1 | -37.51 | -35.91 | -7.95 | -44 | -43.3 | -39.26 | -39.38 | -37.92 | -42.36 | -46.13 | -47.01 | -48.05 | -49.52 | -51.09 | -55.75 |
| Net margin | -686.44% | -886.98% | -23.95% | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -1.020 | -0.9700 | -0.2100 | -1.060 | -0.5500 | -0.4600 | -0.4900 | -0.4700 | -0.5300 | -0.5000 | -0.5147 | -0.5112 | -0.5178 | -0.5013 | -0.5400 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/7/22 | 5/16/22 | 8/8/22 | 11/14/22 | 3/7/23 | 5/9/23 | 8/9/23 | 11/7/23 | 3/19/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 136 | 163 | 53.5 | - | 272 | 398 | 413 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -65.3 | -64.4 | -132 | -134 | - | -184 | -171 | -79.2 |
| ROE (net income / shareholders' equity) | - | -46.3% | -60.9% | -62.2% | - | -76% | -70.1% | -9% |
| ROA (Net income/ Total Assets) | - | -29.6% | -38.1% | -40.6% | - | -55.8% | -54.1% | -7.24% |
| Assets 1 | - | 292.3 | 346.4 | 331.3 | - | 350.4 | 368.2 | 1,614 |
| Book Value Per Share 2 | - | 7.640 | 4.690 | 4.370 | - | 2.580 | 3.190 | 3.050 |
| Cash Flow per Share | - | -1.960 | - | - | - | - | - | - |
| Capex 1 | - | 4.09 | 5.25 | 1.06 | - | 6.13 | 7.78 | 12.8 |
| Capex / Sales | - | 26.54% | 27.89% | 3.21% | - | - | 27.08% | 9.09% |
| Announcement Date | 3/12/20 | 3/9/21 | 3/7/22 | 3/7/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.53
USD
Average target price
26.25
USD
Spread / Average Target
+80.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.71% | 1.16B | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- SRRK Stock
- Financials Scholar Rock Holding Corporation
